Enhancements    

R01: TARGETING NADPH OXIDASE FOR PANCREATIC CANCER PREVENTION AND THERAPY

R01: TARGETING NADPH OXIDASE FOR PANCREATIC CANCER PREVENTION AND THERAPY
PI: Weiqin Lu
Sponsor: NIH - NATIONAL CANCER INSTITUTE
Pharmaceutical Sciences
Amount awarded: $1,032,327

This project determines whether NADPH oxidase is a critical mediator for identifying pancreatic cancer.

Posting date: Mon, 02/13/2023

Award start date: Sat, 10/01/2022
Award end date: Wed, 04/30/2025